The appropriate elicitation of expert opinion in economic models: Making expert data fit for purpose

PharmacoEconomics

Volumn 29, Issue 6, 2011, Pages 455-459

  Sullivan, William ^a   Payne, Katherine ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cost effectiveness; Modelling

Indexed keywords

DECISION MAKING; DELPHI STUDY; ECONOMIC EVALUATION; MATHEMATICAL MODEL; MEDICAL EXPERT; NOTE; PRIORITY JOURNAL;

EXPERT TESTIMONY; HUMANS; MODELS, ECONOMIC; RESEARCH DESIGN;

EID: 79956063222     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11589220-000000000-00000     Document Type: Note

References (23)

1. Akehurst RL. Making decisions on technology availability in the British National Health Service: why we need reliable models. Value Health 2003 Jan-Feb; 6 (1): 3-5. (Pubitemid 36228343)
2. Chilcott J, Brennan A, Booth A, et al. The role of modelling in prioritising and planning clinical trials. Health Technol Assess 2003; 7 (23): iii, 1-125.
3. Philips Z, Bojke L, Sculpher M, et al. Good practice guide- lines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics 2006; 24 (4): 355-71.
4. Weinstein MC, O'Brien B, Hornberger J, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices - Modeling Studies. Value Health 2003 Jan-Feb; 6 (1): 9-17. (Pubitemid 36228345)
5. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE, 2008.
6. Karnon J, Brennan A, Akehurst R. A critique and impact analysis of decision modeling assumptions. Med Decis Making 2007 Jul-Aug; 27 (4): 491-9. (Pubitemid 47106936)
7. Evans C, Crawford B. Expert judgement in pharmaco- economic studies: guidance and future use. Pharmacoeco-nomics 2000 Jun; 17 (6): 545-53. (Pubitemid 30407880)
8. Sculpher M, Drummond M, Buxton M. The iterative use of economic evaluation as part of the process of health technology assessment. J Health Serv Res Policy 1997 Jan; 2 (1): 26-30. (Pubitemid 27077650)
9. Vallejo-Torres L, Steuten LM, Buxton MJ, et al. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach. Int J Tech-nol Assess Health Care 2008 Fall; 24 (4): 459-64.
10. Claxton K, Briggs A, Buxton MJ, et al. Value based pricing for NHS drugs: an opportunity not to be missed? BMJ 2008 Feb 2; 336 (7638): 251-4. (Pubitemid 351251624)
11. Fenwick E, Claxton K, Sculpher M. The value of implementa- tion and the value of information: combined and uneven development. Med Decis Making 2008 Jan-Feb; 28(1): 21-32.
12. Payne K.Fish and chips all round? Regulation of DNA-based genetic diagnostics. Health Econ 2009 Nov; 18 (11): 1233-6.
13. National Institute for Health and Clinical Excellence. Di- agnostics assessment programme: interim methods statement. London: NICE, 2010 [online]. Available from URL: http://www.nice.org.uk/aboutnice/whatwedo/aboutdiag nosticsassessment/?domedia=1&mid=09ECD2A3-19B9-E0B5-D480B5D3F5A9CD76 [Accessed 2010 Sep 9].
14. Lindqvist P, Nordanger UK. (Mis-?) using the E-Delphi method: an attempt to articulate the practical knowledge of teaching. J Res Methods Methodological Issues 2007; 1 (1) [online]. Available from URL: http://www.scientific journals.org/journals2007/articles/1222.pdf [Accessed 2011 Mar 14].
15. Goodman CM. The Delphi technique: a critique. J Adv Nurs 1987 Nov; 12 (6): 729-34.
16. Rauch W. The decision Delphi. Technol Forecast Soc Change 1979; 15: 159-69.
17. Franklin KK, Hart JK. Idea generation and exploration: benefits and limitations of the policy Delphi research method. Innov High Educ 2007; 31: 237-46. (Pubitemid 44771129)
18. Shabaruddin FH, Elliott RA, Valle JW, et al. Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom. Br J Cancer 2010 Jul 27; 103 (3): 315-23.
19. Bojke L, Claxton K, Sculpher M, et al. Characteriz- ing structural uncertainty in decision analytic models: a review and application of methods. Value Health. Epub 2009 Jan 9.
20. Claxton K, Sculpher M, McCabe C, et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 2005 Apr; 14 (4): 339-47. (Pubitemid 40514748)
21. O'Hagan A, Buck CE, Daneshkhah A, et al. Uncertain judgements: eliciting experts' probabilities. Hoboken (NJ): John Wiley & Sons, 2006.
22. Leal J, Wordsworth S, Legood R, et al. Eliciting expert opinion for economic models: an applied example. Value Health 2007 May-Jun; 10 (3): 195-203. (Pubitemid 46802277)
23. Sculpher M. Subgroups and heterogeneity in cost-effectiveness analysis. Pharmacoeconomics 2008; 26 (9): 799-806